Defective Autophagy Leads to the Suppression of Stem-like Features of CD271 Osteosarcoma Cells

Overview

Journal J Biomed Sci

Publisher Biomed Central

Specialty Biology

Date 2016 Nov 20

PMID 27863492

Citations 32

Authors

Dong Zhang

Qing Zhao

Hao Sun

Lijuan Yin

Jiajun Wu

Jun Xu

Tianxiang He

Chunlei Yang

Chengwei Liang

Affiliations

Soon will be listed here.

Abstract

Background: As an important stress-response mechanism, autophagy plays crucial role in the tumor formation and drug resistance of cancer cells including osteosarcoma (OS). OS cancer stem cells (CSCs) also are considered a key factor of tumorigenesis, drug resistance and tumor recurrence. However, the relationship between autophagy and OS CSCs still remains unclear.

Methods: CD271+ OS CSCs and CD271- OS cells were isolated by magnetic activated cell sorting. The autophagy level was evaluated by the mRNA expression of autophagy genes, the protein level of LC3II and p62, and the mean number of GFP-LC3 dot per cell. Lentivirus-delivered specific shRNA was utilized to inhibit the corresponding gene expression. The cell viability was examined with CCK8 assay. The cell proliferation level was detected with BrdU staining assay. Cell death was determined by Annexin V/PI double staining of fluorescence activated cell sorting, lactate dehydrogenase release and caspase-3 activity. Tumorigenicity ability was evaluated by colony and sphere formation assay, the protein expression of stemness markers and tumor formation in nude mice.

Results: Our data indicated that CD271+ OS CSCs had a similar basic autophagy level with CD271- OS cells. Autophagy deficiency had no observable effects on the levels of cell proliferation and death both in CD271+ and CD271- OS cells under normal condition. However, CD271+ OS cells showed a higher autophagy activity than CD271- OS cells under hypoxia and low nutrient (LH) condition. Moreover, autophagy-deficient CD271+ OS cells lost the advantage of tolerance to LH condition compared to CD271- OS cells. Meanwhile, autophagy deficiency enhanced the sensitivity to chemotherapeutics in the CD271+ cells to the comparable level in the CD271- cells. More importantly, deficient-autophagy decreased the protein expression of stemness markers and caused the disappearance of the superiority in tumorigenicity in vitro and vivo in CD271+ OS cells.

Conclusion: The results above demonstrated that autophagy contributes to the stem-like features of CD271+ OS CSCs. Inhibition of autophagy is a promising strategy in the CSCs-targeting OS therapy.

Citing Articles

Understanding the autophagic functions in cancer stem cell maintenance and therapy resistance.

Niharika , Garg M Expert Rev Mol Med. 2024; 26:e23.

PMID: 39375840 PMC: 11488345. DOI: 10.1017/erm.2024.23.

Role of Autophagy and AMPK in Cancer Stem Cells: Therapeutic Opportunities and Obstacles in Cancer.

Kovale L, Singh M, Kim J, Ha J Int J Mol Sci. 2024; 25(16).

PMID: 39201332 PMC: 11354724. DOI: 10.3390/ijms25168647.

Protein homeostasis maintained by HOOK1 levels promotes the tumorigenic and stemness properties of ovarian cancer cells through reticulum stress and autophagy.

Suarez-Martinez E, Piersma S, Pham T, Bijnsdorp I, Jimenez C, Carnero A J Exp Clin Cancer Res. 2024; 43(1):150.

PMID: 38807192 PMC: 11134651. DOI: 10.1186/s13046-024-03071-2.

Combinatorial Therapy: Targeting CD133+ Glioma Stem-like Cells with a Polysaccharide-Prodrug Complex Functionalised Gold Nanocages.

Raveendran S, Giram A, Elmi M, Ray S, Ireson C, Alavijeh M Biomedicines. 2024; 12(5).

PMID: 38790896 PMC: 11117750. DOI: 10.3390/biomedicines12050934.

Emerging Role of Autophagy in Governing Cellular Dormancy, Metabolic Functions, and Therapeutic Responses of Cancer Stem Cells.

Tiwari M, Srivastava P, Abbas S, Jegatheesan J, Ranjan A, Sharma S Cells. 2024; 13(5.

PMID: 38474411 PMC: 10930960. DOI: 10.3390/cells13050447.

References

Wu S, Wang X, Chen J, Chen Y . Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells. Biochem Biophys Res Commun. 2013; 434(4):898-903. DOI: 10.1016/j.bbrc.2013.04.053. View

Ying M, Liu G, Shimada H, Ding W, May W, He Q . Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity. Oncogene. 2012; 32(36):4252-63. PMC: 3947577. DOI: 10.1038/onc.2012.438. View

Fu J, Liu Z, Liu X, Chen F, Shi H, Pangjesse C . Glioblastoma stem cells resistant to temozolomide-induced autophagy. Chin Med J (Engl). 2009; 122(11):1255-9. View

Gong C, Bauvy C, Tonelli G, Yue W, Delomenie C, Nicolas V . Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene. 2012; 32(18):2261-72, 2272e.1-11. PMC: 3679409. DOI: 10.1038/onc.2012.252. View

He A, Yang X, Huang Y, Feng T, Wang Y, Sun Y . CD133(+) CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma. J Cell Biochem. 2015; 116(8):1719-29. DOI: 10.1002/jcb.25131. View

Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo J . Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. Stem Cells Int. 2016; 2016:3631764. PMC: 4913005. DOI: 10.1155/2016/3631764. View

Shimizu T, Sugihara E, Yamaguchi-Iwai S, Tamaki S, Koyama Y, Kamel W . IGF2 preserves osteosarcoma cell survival by creating an autophagic state of dormancy that protects cells against chemotherapeutic stress. Cancer Res. 2014; 74(22):6531-41. DOI: 10.1158/0008-5472.CAN-14-0914. View

Bielack S, Kempf-Bielack B, Delling G, Exner G, Flege S, Helmke K . Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002; 20(3):776-90. DOI: 10.1200/JCO.2002.20.3.776. View

Wilson H, Huelsmeyer M, Chun R, Young K, Friedrichs K, Argyle D . Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J. 2007; 175(1):69-75. DOI: 10.1016/j.tvjl.2007.07.025. View

10.

Ojha R, Jha V, Singh S, Bhattacharyya S . Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer. Biochim Biophys Acta. 2014; 1842(11):2073-86. DOI: 10.1016/j.bbadis.2014.07.007. View

11.

Tian J, Li X, Si M, Liu T, Li J . CD271+ osteosarcoma cells display stem-like properties. PLoS One. 2014; 9(6):e98549. PMC: 4043643. DOI: 10.1371/journal.pone.0098549. View

12.

Sun K, Deng W, Zhang S, Cai N, Jiao S, Song J . Paradoxical roles of autophagy in different stages of tumorigenesis: protector for normal or cancer cells. Cell Biosci. 2013; 3(1):35. PMC: 3849558. DOI: 10.1186/2045-3701-3-35. View

13.

Song Y, Zhang S, Guo X, Sun K, Han Z, Li R . Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Cancer Lett. 2013; 339(1):70-81. DOI: 10.1016/j.canlet.2013.07.021. View

14.

Yang H, Ma Y, Zhou Y, Xu L, Chen X, Ding W . Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment. Cancer Lett. 2015; 361(1):128-36. DOI: 10.1016/j.canlet.2015.02.045. View

15.

Liu Y, Zhao L, Ju Y, Li W, Zhang M, Jiao Y . A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drug resistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF). Cell Death Dis. 2014; 5:e1361. PMC: 4454296. DOI: 10.1038/cddis.2014.300. View

16.

Cufi S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Vellon L, Menendez J . Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype. Cell Cycle. 2011; 10(22):3871-85. DOI: 10.4161/cc.10.22.17976. View

17.

Zhu H, Wang D, Liu Y, Su Z, Zhang L, Chen F . Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells. Cancer Cell Int. 2013; 13(1):119. PMC: 4177138. DOI: 10.1186/1475-2867-13-119. View

18.

Kuo T, Chen C, Baron D, Onder T, Loewer S, Almeida S . Midbody accumulation through evasion of autophagy contributes to cellular reprogramming and tumorigenicity. Nat Cell Biol. 2011; 13(10):1214-23. PMC: 4208311. DOI: 10.1038/ncb2332. View

19.

Fu Y, Chang H, Peng X, Bai Q, Yi L, Zhou Y . Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway. PLoS One. 2014; 9(7):e102535. PMC: 4113212. DOI: 10.1371/journal.pone.0102535. View

20.

Yue W, Hamai A, Tonelli G, Bauvy C, Nicolas V, Tharinger H . Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy. 2013; 9(5):714-29. PMC: 3669181. DOI: 10.4161/auto.23997. View